Sedation Pipeline Insights Report 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Sedation - Pipeline Insights, 2017" drug pipelines to their offering.

Sedation - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Sedation.

The This report covers the product profiles in various stages of development including Discovery, Pre - clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Sedation.

This report also assesses the Sedation therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Key Topics Covered:

1. Sedation Overview
2. Sedation Disease Associated
3. Sedation Pipeline Therapeutics
4. Sedation Therapeutics under Development by Companies
5. Sedation Filed and Phase III Products
6. Sedation Phase II Products
7. Sedation Phase I and IND Filed Products
8. Sedation Discovery and Pre-Clinical Stage Products
9. Drug Candidate Profiles
10. Sedation - Therapeutics Assessment
11. Sedation - Discontinued Products
12. Sedation - Dormant Products
13. Companies Involved in Therapeutics Development for Sedation
14. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/7jkghs/sedation